Jazz Pharmaceuticals plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Jazz Pharmaceuticals plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Jazz Pharmaceuticals plc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $73.1M, a 5.95% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $73.1M +$4.11M +5.95% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $61.6M -$13.9M -18.4% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $65.3M -$7.99M -10.9% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $65M -$8.69M -11.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $69M -$9.33M -11.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $75.5M -$7.87M -9.44% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $73.3M -$13.3M -15.3% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $73.7M -$15.9M -17.7% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $78.4M -$70.9M -47.5% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $83.4M -$42.3M -33.7% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $86.6M -$42.6M -33% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $89.6M -$41.1M -31.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $149M +$16.1M +12.1% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $126M -$10.2M -7.53% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $129M -$10.2M -7.33% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $131M -$11.2M -7.87% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $133M -$11.6M -7.99% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $136M -$11.4M -7.73% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $139M +$139M Dec 31, 2019 10-K 2021-02-23
Q3 2019 $142M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $145M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $147M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.